Celgene Corp's first foray into autoimmune disease, Otezla, notched FDA approval last year as a therapy for psoriasis, and its sales have been building steadily ever since, including an impressive 688 ...

Celgene's ($CELG) Otezla is the newest entrant in what is shaping up to be a summer throwdown among psoriasis drugmakers. Not surprisingly, every company's got its ...

Headache, upper respiratory infection, and nausea are some of Otezla’s more common side effects. As your body gets used to Otezla, some side effects may reduce or go away. This can take around 2 weeks ...

Otezla (apremilast) is an oral tablet commonly used to treat psoriatic arthritis in adults. Psoriatic arthritis is a long-lasting condition that affects the joints in people with psoriasis. Common ...

Otezla (apremilast) is an oral tablet commonly used to treat plaque psoriasis in adults and children. Plaque psoriasis is an inflammatory skin condition that causes itchy, painful patches on the skin.

Odds are that anyone who has watched cable news of late has seen a commercial for Celgene ’s Otezla treatment for the skin condition psoriasis and psoriatic arthritis or one for its larger rival ...

Otezla (apremilast) and Humira (adalimumab) are prescription drugs used to treat plaque psoriasis and psoriatic arthritis in adults. Otezla comes as an oral tablet, and Humira comes as a liquid ...

Celgene announced the release of new research findings on Otezla (apremilast), a selective inhibitor of phosphodiesterase 4 (PDE4), from the ESTEEM 1 and 2 Phase 3 studies in patients with moderate to ...

Otezla (apremilast) is a brand-name oral tablet that’s prescribed for conditions such as psoriatic arthritis. The drug’s cost with and without insurance can depend on several factors, such as whether ...

Please provide your email address to receive an email when new articles are posted on . According to the psoriatic arthritis MRI score, Otezla decreased inflammation 2.32 points from baseline. Otezla ...